Cargando…

Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients

INTRODUCTION: Quantification of serum-free light chains (FLCs) is important in the diagnosis and monitoring of paraprotein-related diseases. There are currently 2 FLC assays available: the Freelite assay (Binding Site) and the N Latex assay (Siemens). There is emerging evidence that these assays giv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sprangers, Ben, Claes, Kathleen, Evenepoel, Pieter, Kuypers, Dirk, Poesen, Koen, Delforge, Michel, Bossuyt V, Xavier, Meijers, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210599/ https://www.ncbi.nlm.nih.gov/pubmed/32405584 http://dx.doi.org/10.1016/j.ekir.2020.01.019

Ejemplares similares

Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease
por: Poesen, Ruben, et al.
Publicado: (2014)

Two Cases of Heavy Chain MGUS
por: Van Keer, Jan, et al.
Publicado: (2016)

Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study
por: Vandenbosch, Ines, et al.
Publicado: (2020)

Discrepancies between bioimpedance spectroscopy devices in haemodialysis patients
por: Dejongh, Sander, et al.
Publicado: (2019)

Prognostic value of neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
por: Godelaine, Joris, et al.
Publicado: (2021)

The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial
por: Poesen, Ruben, et al.
Publicado: (2016)

The clinical significance of atypical indirect immunofluorescence patterns on primate cerebellum in paraneoplastic antibody screening
por: Godelaine, Joris, et al.
Publicado: (2019)

The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites
por: Poesen, Ruben, et al.
Publicado: (2015)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Comparison of two free light chain assays: performance of the involved free light chain ratio and implications for diagnosis of multiple myeloma
por: Willrich, Maria Alice V., et al.
Publicado: (2022)

A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System
por: Meijers, Björn, et al.
Publicado: (2012)

Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016)

Analytical and clinical concordance of free light chain assay
por: Smith, Andrew, et al.
Publicado: (2018)

Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease
por: De Maré, Annelies, et al.
Publicado: (2019)

Heritability and Clinical Determinants of Serum Indoxyl Sulfate and p-Cresyl Sulfate, Candidate Biomarkers of the Human Microbiome Enterotype
por: Viaene, Liesbeth, et al.
Publicado: (2014)

The Role of Gut Dysbiosis in the Bone–Vascular Axis in Chronic Kidney Disease
por: Evenepoel, Pieter, et al.
Publicado: (2020)

Effects of an SGLT Inhibitor on the Production, Toxicity, and Elimination of Gut-Derived Uremic Toxins: A Call for Additional Evidence
por: Evenepoel, Pieter, et al.
Publicado: (2022)

Silver Nanoparticle-Based Assay for the Detection of Immunoglobulin Free Light Chains
por: Lizoń, Anna, et al.
Publicado: (2019)

Verification study of free light chains assays on reagent-optimized analysers
por: Šegulja, Dragana, et al.
Publicado: (2019)

Intestinal Barrier Function in Chronic Kidney Disease
por: Meijers, Björn, et al.
Publicado: (2018)

Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
por: Vandenbussche, Nicolas, et al.
Publicado: (2017)

Food-Derived Uremic Toxins in Chronic Kidney Disease
por: Lauriola, Mara, et al.
Publicado: (2023)

Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?
por: Cappuyns, Sarah, et al.
Publicado: (2022)

Management of fracture risk in CKD—traditional and novel approaches
por: Haarhaus, Mathias, et al.
Publicado: (2022)

The uremic retention solute p-cresyl sulfate alters NO signal transduction by alteration of the soluble guanylate cyclase redox state
por: Meijers, Björn KI, et al.
Publicado: (2009)

Clinical Comparisons of Two Free Light Chain Assays to Immunofixation Electrophoresis for Detecting Monoclonal Gammopathy
por: Kim, Han-Sung, et al.
Publicado: (2014)

Comparison of Freelite and N-Latex serum free light chain assays: a critical review
por: Daves, Massimo, et al.
Publicado: (2021)

The Chromosomal Conformation Signature: A New Kid on the Block in ALS Biomarker Research?
por: Poesen, Koen
Publicado: (2018)

Comment on “Clinical Comparisons of Two Free Light Chain Assays to Immunofixation Electrophoresis for Detecting Monoclonal Gammopathy”
por: Parker, Antony R., et al.
Publicado: (2015)

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
por: Abroud, Hajer, et al.
Publicado: (2022)

Role of serum‐free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
por: Tacchetti, Paola, et al.
Publicado: (2022)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

IgG4-related disease should be considered in cases of hypocomplementemic immune-complex tubulointerstitial nephritis
por: Sprangers, Ben, et al.
Publicado: (2010)

Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains
por: Wilhite, Dorian, et al.
Publicado: (2021)

Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials
por: Sprangers, Ben, et al.
Publicado: (2022)

Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease
por: Yang, Yang, et al.
Publicado: (2019)

Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma
por: Schieferdecker, Aneta, et al.
Publicado: (2020)

Evaluation of Correlation between Serum Free Light-Chain Assay and Bone Marrow Study in Multiple Myeloma Patients
por: Zamani, Fatemeh, et al.
Publicado: (2021)

Peptides From the Variable Domain of Immunoglobulin G as Biomarkers in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Godelaine, Joris, et al.
Publicado: (2023)

The clinical utility of serum free light chain and heavy/light chain assays in monitoring disease activity in patients with IgG myeloma after achieving a deep response
por: Shimizu, Kazuyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_20ri9025074t0vbdlml6rjsdks